scholarly journals Updates on Translational Research on Prevention of Polyps and Colorectal Cancer

2018 ◽  
Vol 31 (03) ◽  
pp. 153-160 ◽  
Author(s):  
Elena Stoffel

AbstractMorbidity and mortality from colorectal cancer (CRC) can be effectively reduced through early detection and prevention. To date, strategies for managing CRC risk have focused primarily on secondary prevention, through screening asymptomatic individuals for colorectal neoplasia. In the United States, implementation of screening among individuals age ≥50 has led to not only decreased CRC-related mortality but also reduced CRC incidence through colonoscopic removal of precancerous polyps. In contrast to screening's endpoint of early detection, the goal of primary prevention of CRC is to arrest and/or reverse colorectal carcinogenesis. Observational studies and randomized clinical trials continue to examine effects of specific pharmacologic agents (chemoprevention) and dietary interventions on development of advanced colorectal neoplasia. This review will present an overview of strategies for primary and secondary prevention of CRC, including endoscopic, pharmacologic, and dietary interventions.

2016 ◽  
Vol 29 (04) ◽  
pp. 353-362 ◽  
Author(s):  
Scott Dolejs ◽  
Benjamin Gayed ◽  
Alyssa Fajardo

AbstractColorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality worldwide. There are well-established screening protocols involving fecal testing, radiographic, and endoscopic evaluations that have led to decreased incidence and mortality of CRC in the United States. In addition to screening for CRC, there is interest in preventing colorectal neoplasia by targeting the signaling pathways that have been identified in the pathway of dysplasia progressing to carcinoma. This review will detail the efficacy of multiple potential preventative strategies including lifestyle changes (physical activity, alcohol use, smoking cessation, and obesity); dietary factors (dietary patterns, calcium, vitamin D, fiber, folate, and antioxidants and micronutrients); and chemopreventive agents (nonsteroidal anti-inflammatory drugs, statins, metformin, bisphosphonates, and postmenopausal hormonal therapy).


2014 ◽  
Vol 7 ◽  
pp. CGast.S14039 ◽  
Author(s):  
Pedro J. Tárraga López ◽  
Juan Solera Albero ◽  
José Antonio Rodríguez-Montes

Introduction Cancer is a worldwide problem as it will affect one in three men and one in four women during their lifetime. Colorectal cancer (CRC) is the third most frequent cancer in men, after lung and prostate cancer, and is the second most frequent cancer in women after breast cancer. It is also the third cause of death in men and women separately, and is the second most frequent cause of death by cancer if both genders are considered together. CRC represents approximately 10% of deaths by cancer. Modifiable risk factors of CRC include smoking, physical inactivity, being overweight and obesity, eating processed meat, and drinking alcohol excessively. CRC screening programs are possible only in economically developed countries. However, attention should be paid in the future to geographical areas with ageing populations and a western lifestyle. 19 , 20 Sigmoidoscopy screening done with people aged 55-64 years has been demonstrated to reduce the incidence of CRC by 33% and mortality by CRC by 43%. Objective To assess the effect on the incidence and mortality of CRC diet and lifestyle and to determine the effect of secondary prevention through early diagnosis of CRC. Methodology A comprehensive search of Medline and Pubmed articles related to primary and secondary prevention of CRC and subsequently, a meta-analysis of the same blocks are performed. Results 225 articles related to primary or secondary prevention of CRC were retrieved. Of these 145 were considered valid on meta-analysis: 12 on epidemiology, 56 on diet and lifestyle, and over 77 different screenings for early detection of CRC. Cancer is a worldwide problem as it will affect one in three men and one in four women during their lifetime. There is no doubt whatsoever which environmental factors, probably diet, may account for these cancer rates. Excessive alcohol consumption and cholesterol-rich diet are associated with a high risk of colon cancer. A diet poor in folic acid and vitamin B6 is also associated with a higher risk of developing colon cancer with an overexpression of p53. Eating pulses at least three times a week lowers the risk of developing colon cancer by 33%, after eating less meat, while eating brown rice at least once a week cuts the risk of CRC by 40%. These associations suggest a dose–response effect. Frequently eating cooked green vegetables, nuts, dried fruit, pulses, and brown rice has been associated with a lower risk of colorectal polyps. High calcium intake offers a protector effect against distal colon and rectal tumors as compared with the proximal colon. Higher intake of dairy products and calcium reduces the risk of colon cancer. Taking an aspirin (ASA) regularly after being diagnosed with colon cancer is associated with less risk of dying from this cancer, especially among people who have tumors with COX-2 overexpression. 16 Nonetheless, these data do not contradict the data obtained on a possible genetic predisposition, even in sporadic or non-hereditary CRC. CRC is susceptible to screening because it is a serious health problem given its high incidence and its associated high morbidity/mortality. Conclusions (1) Cancer is a worldwide problem. (2) A modification of diet and lifestyle could reduce morbidity and mortality. (3) Early detection through screening improves prognosis and reduces mortality.


2019 ◽  
Vol 111 (10) ◽  
pp. 1104-1106 ◽  
Author(s):  
Rebecca L Siegel ◽  
Genet A Medhanie ◽  
Stacey A Fedewa ◽  
Ahmedin Jemal

Abstract The extent to which the increase in early-onset colorectal cancer (CRC) in the United States varies geographically is unknown. We analyzed changes in CRC incidence and risk factors among people aged 20–49 years by state using high-quality population-based cancer registry data provided by the North American Association of Central Cancer Registries and national survey data, respectively. Early-onset CRC incidence was mostly stable among blacks and Hispanics but increased in 40 of 47 states among non-Hispanic whites, most prominently in western states. For example, rates increased in Washington from 6.7 (per 100 000) during 1995–1996 to 11.5 during 2014–2015 (rate ratio = 1.73, 95% confidence interval = 1.48 to 2.01) and in Colorado from 6.0 to 9.5 (rate ratio = 1.57, 95% confidence interval = 1.30 to 1.91). Nevertheless, current CRC incidence was highest in southern states. From 1995 to 2005, increases occurred in obesity prevalence in all states and heavy alcohol consumption in one-third of states, but neither were correlated with CRC incidence trends. Early-onset CRC is increasing most rapidly among whites in western states. Etiologic studies are needed to explore early life colorectal carcinogenesis.


Author(s):  
Hemant Mutneja ◽  
Rohit Agrawal ◽  
Abhishek Bhurwal ◽  
Shilpa Arora ◽  
Andrew Go ◽  
...  

Background and Aims: Fecal immunochemical tests (FITs) and flexible sigmoidoscopies are commonly used modalities for colorectal cancer (CRC) screening. We performed a systematic review and meta-analysis to compare the effectiveness of FIT and sigmoidoscopy in CRC screening. Methods: PRISMA statement and Cochrane guidelines were followed for this review. Digital dissertation databases were searched from inception till December 1st 2020 and randomized clinical trials comparing the detection rates of CRC for FIT and sigmoidoscopy were included. Outcomes for analysis included participation rates and detection rates of CRC, advanced adenomas and advanced colorectal neoplasia for both screening modalities. Results: Five randomized clinical trials with a total of 261,755 patients were included for the analysis. The participation rate for FIT was significantly higher compared to flexible sigmoidoscopy (OR 2.11, 95% CI 1.29-3.44, p=0.003). In intention-to-screen analysis, the detection rate for advanced colorectal neoplasia was significantly lower with FIT (OR 0.62, 95% CI 0.45-0.84, p=0.002) as compared to flexible sigmoidoscopy but not statistically different for CRC (OR 1.15, 95% CI 0.65-2.02, p=0.63). Conclusion: Despite lower participation amongst patients, CRC screening with flexible sigmoidoscopy leads to higher detection of advanced colorectal neoplasia, when compared to a single round of fecal immunochemical testing.


2018 ◽  
Author(s):  
Alfred I. Neugut ◽  
David P Wu

Recently surpassing heart disease, cancer is now the leading cause of death (one in four) in the United States. Worldwide, cancer control is becoming increasingly important as life expectancy improves because of lower infant mortality and fewer deaths from infectious diseases. Morbidity and mortality from many forms of cancer can be controlled through primary or secondary prevention. Primary prevention can be defined as risk modification to lower cancer occurrence. Secondary prevention refers to the use of screening tests to detect cancers at early stages. Environmental carcinogens, inherited factors that predispose to cancer, and screening and early detection are covered in major sections. Also included are discussions of infectious agents, occupational carcinogens, iatrogenic causes, carcinogens affecting the reproductive system, and miscellaneous environmental causes. Tables outline established causes of human cancer, common hereditary cancers and syndromes attributable to germline mutations in predisposing genes, and the American Cancer Society’s recommendations for early detection of cancer. This chapter contains 138 references.


2020 ◽  
Vol 3 (1) ◽  
Author(s):  
Kwan-Liang Lye ◽  
Loh Teng-Hern Tan ◽  
Hui-Min Yap

The colorectal cancer is among the most predominant cancer in the world including Malaysia. Numerous factors could contribute towards colorectal carcinogenesis and one of the factors is genetic predisposition. Mutations in the V-KiRas2 (Kras) oncogene have been implicated in 30-50% of the colorectal cancer patients and usually lead to poorer prognosis. The challenging ability for the early detection of colorectal cancer still poses an enormous challenge to oncologist as there are limited or no signs or symptoms in the early stage of colorectal cancer. Many studies were conducted hoping to further understand colorectal cancer for a better diagnosis and prognosis. As early detection of colorectal cancer frequently leads to good prognosis. The gold standard for prognosis depends on the stage of the tumor at the time of diagnosis. Lately a group of small, non-coding RNAs termed microRNAs (miRNAs) exhibited capable outcomes in cancer research. Numerous miRNAs were discovered to play a key role in regulatory mechanism in numerous cancers. Differential miRNAs expression among tumors and non-tumor controls are highly valuable in recognizing miRNAs that could have vital role in carcinogenesis. Recently some miRNAs were discovered to play a vital role in colorectal carcinogenesis. Thus, miRNAs have emerged as highly useful tool for scientists to comprehend carcinogenesis better. For example, miR-21 and miR-106a were highly expressed in colorectal cancer. While miRNAs including miR-17-92 cluster, miR-21, miR-34, miR-135 and miR-196a also exhibited high association with colorectal cancer. Therefore, this article aims to provide insight of miRNAs role in colorectal cancer for a better understanding of this disease.


2017 ◽  
Author(s):  
Alfred I. Neugut ◽  
David P Wu

Recently surpassing heart disease, cancer is now the leading cause of death (one in four) in the United States. Worldwide, cancer control is becoming increasingly important as life expectancy improves because of lower infant mortality and fewer deaths from infectious diseases. Morbidity and mortality from many forms of cancer can be controlled through primary or secondary prevention. Primary prevention can be defined as risk modification to lower cancer occurrence. Secondary prevention refers to the use of screening tests to detect cancers at early stages. Environmental carcinogens, inherited factors that predispose to cancer, and screening and early detection are covered in major sections. Also included are discussions of infectious agents, occupational carcinogens, iatrogenic causes, carcinogens affecting the reproductive system, and miscellaneous environmental causes. Tables outline established causes of human cancer, common hereditary cancers and syndromes attributable to germline mutations in predisposing genes, and the American Cancer Society’s recommendations for early detection of cancer. This chapter contains 138 references.


2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
O Majek ◽  
O Ngo ◽  
B Seifert ◽  
S Suchanek ◽  
M Zavoral ◽  
...  

Abstract Issue Colorectal cancer (CRC) has been among the most important cancer causes of death globally. CRC screening and early detection can decrease CRC incidence and mortality through timely removal of colorectal neoplasia or early CRC treatment. CRC screening has been initiated in the Czech Republic in 2000 for individuals over 50, with GPs having a key role in recruiting individuals to screening, offering faecal occult blood test (FOBT). Screening colonoscopy (CS) was added for individuals over 55 since 2009. Description of the problem To increase uptake of CRC screening, personal invitation of non-attenders under 70 was implemented in 2014, along with temporary mass-media campaign. Health insurance companies have been sending invitations to those individuals without record of recent FOBT, CS or CRC treatment. The aim of our study was to evaluate impact of this policy on complete coverage by examination over 2013-2018. We defined the complete coverage by examination as the proportion of individuals aged 50-69 undergoing examination with CRC early detection potential (FOBT or CS for any indication) during past 3 years. We used newly established National Registry of Reimbursed Health Services as the source of data. Results Complete coverage of the target population (2.7 million individuals aged 50-69) was 44.8 % in 2013. By 2016, the coverage increased to 54.6%. Therefore, almost 300,000 individuals were newly covered by the relevant examinations. By 2018, the coverage decreased to 51.2%. When we consider only screening FOBT examinations, the coverage was 36.9 % in 2013, 45.2% in 2016, and 42.0% in 2018. Lessons In the health system with accessible CS facilities, the policy of non-attenders' invitation for CRC screening resulted not only in increase in coverage by screening examinations; complete coverage also increased. Unfortunately, the positive effect has been fading out, and further actions to sustain high coverage are therefore warranted. Key messages Invitation of non-attenders to colorectal cancer screening increased complete coverage of the target population by examination. Initial increase was followed by a slow decrease in coverage by examination, underlying the need for other actions to increase participation.


1996 ◽  
Vol 3 (1) ◽  
pp. 20-25 ◽  
Author(s):  
Bernard Levin

Colorectal cancer is a major cause of morbidity and mortality in the United States. Early detection of the disease at an asymptomatic stage by screening holds promise for lowering the incidence of colorectal cancer deaths, yet compliance with screening guidelines is poor. Evidence in support of the use of screening techniques for colorectal cancer is accumulating, however, and screening for this disease with fecal occult blood tests and flexible sigmoidoscopy can increase the likelihood of early detection, can decrease mortality and morbidity, and can be cost effective.


Sign in / Sign up

Export Citation Format

Share Document